The meperidine is also known as pethidine. It is a synthetic opioid analgesic and used in pain management. It is also used to treat rigors and in post anesthesia-shivers. Several physicians prefer to prescribe meperidine for the treatment of acute and chronic severe pain as it has lesser risk of addiction and is safer than morphine. However, due to the short duration of action, low potency and toxicity of meperidine compared to other opioid analgesics, the preference for meperidine among physicians has reduced in the recent years.
Market Dynamics
The growing demand for meperidine is associated with its increasing use as an anesthetic in different surgical procedures. According to the World Health Organization (WHO), around 232 million surgeries were reported in 2013, suggesting that the increase in number of surgical procedures is expected to support the growth of meperidine segment in the near future. Moreover, as per the Centers for Disease Control and Prevention (CDC), in 2014, surgical procedures were the second largest contributors in opioid prescriptions and contributed around 37% in total opioid prescriptions in the U.S. These factors are expected to support the global meperidine (Demerol) market growth during the forecast period.
Key features of the study:
This report provides in-depth analysis of the global meperidine (Demerol) market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period: 2020- 2027, considering 2019 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global meperidine (Demerol) market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Key companies covered as a part of this study are Pfizer, Inc., Hikma Pharmaceuticals USA Inc., Epic Pharma, Inc., Teva Pharmaceutical Industries Ltd., and Vintage Pharmaceuticals, Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, end user upgrades, market expansion, and marketing tactics
The global meperidine (Demerol) market report caters to various stakeholders in this industry, including investors, device/system manufacturers, distributors and suppliers, research and consulting firms, new entrants, and financial analysts
Various strategy matrices used in analyzing the meperidine (Demerol) market would provide stakeholders vital inputs to make strategic decisions
Detailed Segmentation
Global Meperidine (Demerol) Market, By Dosage Form:
Tablet
Injection
Syrup
Global Meperidine (Demerol) Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Meperidine (Demerol) Market, By Region:
North America
By Dosage Form:
Tablet
Injection
Syrup
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Europe
By Dosage Form:
Tablet
Injection
Syrup
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Latin America
By Dosage Form:
Tablet
Injection
Syrup
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Asia Pacific
By Dosage Form:
Tablet
Injection
Syrup
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Dosage Form:
Tablet
Injection
Syrup
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Dosage Form:
Tablet
Injection
Syrup
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Pfizer, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Strategies
Hikma Pharmaceuticals USA Inc.
Epic Pharma, Inc.
Teva Pharmaceutical Industries Ltd.
Vintage Pharmaceuticals, Inc.
Like it? Share it!
About the Author
Trupti Joined: March 17th, 2021 Articles Posted: 36
